SURVYR

ILMN

Illumina, Inc.
$288.79
+$9.32 (3.33%)Oct 28 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-7%+47%+101%+154%+208%Oct 2025Oct 2026Apr 202652w high $309.3552w low $94.00
ILMNSPY
Wall St. Highest PT $365.00 (+26.4%) Wall St. Avg PT $245.80 (-14.9%)
$95$165$235$306$376POC $131Hi $365Avg $246
Underwater Drawdown %Max DD -25.7%Current -1.7%
0.0%-25.7%
Relative Strength vs SPY+173.9% vs SPYOutperforming
+205%0%-205%
1W
+$5.93 (2.10%)
1M
+$16.89 (6.21%)
3M
+$93.97 (48.23%)
6M
+$168.42 (139.92%)
YTD
+$157.63 (120.18%)
1Y
+$190.99 (195.29%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
20 analysts · mean score 2.43
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$288.79
Average target$245.80
−$42.99 (−14.9%) downsideaverage target vs current price
CurrentAverageMedian
Low$113.00
Median$245.80
High$365.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$42.7B
P/E (last 12 months)52.8
P/E (next 12 months, estimated)46.2
52-week range$94.00 – $309.35
Revenue growth (latest quarter vs a year ago)+9.4%
Dividend yieldNo dividend
Analyst consensusBuy (20)
Average analyst price target$245.80 (-15%)

What they do

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.

Healthcare · Diagnostics & Research
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
99th percentile in sector
A+
12-1 return: +121.5%
Percentile within its GICS sector across the S&P 1500.
Growth
54th percentile in sector
C+
Revenue growth (YoY): +9.4%
Percentile within its GICS sector across the S&P 1500.
Value
9th percentile in sector
D-
Forward E/P: 2.3% · EBITDA/EV: 2.8%
Percentile within its GICS sector across the S&P 1500.
Profitability
83rd percentile in sector
A-
Profit margin: +18.3% · Return on equity: +32.3%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
ranked 91 of 360 · Composite (0-1) 0.6
 Momentum Top 15
ranked 18 of 499 · 12-month momentum 124.9%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

ILMN earningsReports today
Next report · quarter Sep 2026
Thu Oct 29, 2026After the close
EPS consensus$1.36
Revenue consensus–
Last 4 quarters · EPS vs estimate
Jul 30, 2026$1.31est $1.23+6.8%Above estimates
Apr 30, 2026$1.15est $1.05+9.0%Above estimates
Feb 5, 2026$1.35est $1.23+9.7%Above estimates
Oct 30, 2025$1.34est $1.17+14.7%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-26 18:46:07 ET
24-1125-0225-0525-0725-1026-0226-0426-070.001.35
EstimateActual (beat)Actual (miss)

News & catalysts

More news
Twist Bioscience Sinks 9%, Illumina Down 5% as AI and Genomics Stocks Slide
TIKR · Oct 22
Illumina stock may move 9.3% on earnings release
Investing.com · Oct 22
Invesco S&P 500 Equal Weight ETF (RSP) Sells $0.7 Million of Moderna on Tuesday
GuruFocus.com · Oct 22
How Long Can GeneDx Keep Burning Cash?
Trefis · Oct 21
Illumina To Webcast Upcoming Investor Conference
PR Newswire · Oct 20
Insider trades
Meister Keith A.
Director · 2026-09-04
Sell
$2.5M
Meister Keith A.
Director · 2026-09-04
Sell
$22.0M
Meister Keith A.
Director · 2026-09-04
Sell
$1.6M
Meister Keith A.
Director · 2026-09-03
Sell
$2.2M
Meister Keith A.
Director · 2026-09-03
Sell
$1.5M
Meister Keith A.
Director · 2026-09-03
Sell
$3.0M
Meister Keith A.
Director · 2026-09-03
Sell
$2.1M
Meister Keith A.
Director · 2026-09-03
Sell
$3.1M
Meister Keith A.
Director · 2026-09-03
Sell
$2.9M
Meister Keith A.
Director · 2026-09-03
Sell
$1.8M
Meister Keith A.
Director · 2026-09-02
Sell
$2.3M
Meister Keith A.
Director · 2026-09-02
Sell
$12.3M

Stats refreshed 2026-10-26 18:46:07 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026